Clinical Trials Browser

Recruiting × Advanced Solid Tumours × 30 days × Clear all

NCT06795412 2026-03-06

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumours